P. Birch

Investigation of six novel susceptibility loci for male androgenetic alopecia in women with female pattern hair loss.

M. Nöthen, T. Becker, R. Tazi-Ahnini, 2013, Journal of dermatological science.

The immunohistochemical detection of cripto‐1 in benign and malignant human bladder

D. Neal, M. Robinson, W. Gullick, 1998, The Journal of pathology.

Oncoprotein immunoreactivity in human pituitary tumours

D. Harrison, P. Ince, M. Daniels, 1994, Clinical endocrinology.

Selected variants of the melanocortin 4 receptor gene (MC4R) do not confer susceptibility to female pattern hair loss

M. Nöthen, T. Becker, R. Tazi-Ahnini, 2013, Archives of Dermatological Research.

The oestrogen receptor 2 (ESR2) gene in female‐pattern hair loss: replication of association with rs10137185 in German patients

T. Becker, R. Tazi-Ahnini, D. Drichel, 2014, The British journal of dermatology.

Investigation of four novel male androgenetic alopecia susceptibility loci: no association with female pattern hair loss

M. Nöthen, T. Becker, R. Tazi-Ahnini, 2014, Archives of Dermatological Research.

Glutathione-S-Transferase π Expression in Transitional Cell Carcinoma of the Bladder

D. Neal, M. Robinson, S. Clifford, 1993 .

Cripto-1 is a tumour specific marker of bladder cancer

D. Neal, M. Robinson, W. Gullick, 1997 .